$133.82
Price
$4.6B
Market Cap
52.7
P/E Ratio
45.3
Forward P/E
$2.54
EPS (TTM)
—
Dividend Yield
$466M
Cash
$518M
Total Debt
34M
Shares Out
$62.07
$156.00
52-Week Range
Institutional Ownership of TRANSMEDICS GROUP INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for TRANSMEDICS GROUP INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| No activity found for this stock. | |||||
Insider Trading for TRANSMEDICS GROUP INC
6 Months Insider Sentiment
Buy $1.0M
Sell $1.8M
1
Buys
4
Sells
-797K
Net
0
Grants
Largest
$1.0M
Hassanein
$693K
Weill
$540K
Basile
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 04, 2025 | Gerardo Hernandez | Chief Financial Officer | SELL | 920 | $139.62 | $128K |
| Dec 03, 2025 | David Weill | Director | EXERCISE | 5.0K | $14.20 | $71K |
| Dec 03, 2025 | David Weill | Director | SELL | 5.0K | $138.64 | $693K |
| Nov 25, 2025 | Anil P. Ranganath | Senior Vice President, General Counsel and Secretary | SELL | 3.0K | $145.22 | $436K |
| Nov 25, 2025 | Anil P. Ranganath | Senior Vice President, General Counsel and Secretary | EXERCISE | 3.0K | $93.88 | $282K |
| Nov 17, 2025 | Waleed H Hassanein | President & CEO | BUY | 8.8K | $114.00 | $1.0M |
| Oct 29, 2025 | Edward M Basile | Director | SELL | 4.1K | $130.45 | $540K |
| Oct 29, 2025 | Edward M Basile | Director | EXERCISE | 4.1K | $0.70 | $3K |